What color blood collection tubes should be used for baseline serologies (HBsAg, anti‑HCV antibody, HIV antibody, ALT), complete blood count, renal‑function tests, and HCV RNA PCR in a patient receiving HIV post‑exposure prophylaxis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Blood Collection Tubes for HIV Post-Exposure Prophylaxis Baseline Testing

For baseline serologies (HBsAg, anti-HCV antibody, HIV antibody, ALT), complete blood count, renal function tests, and HCV RNA PCR in HIV post-exposure prophylaxis, use the following tubes: red-top or serum separator tube (SST/gold-top) for serologies and chemistry tests including ALT and renal function; lavender-top (EDTA) tube for complete blood count; and lavender-top or plasma processing tube for HCV RNA PCR.

Specific Tube Requirements by Test Type

Serologies and Chemistry Panel

  • Red-top (no additive) or Gold-top/Tiger-top (serum separator tube) for:
    • HBsAg (hepatitis B surface antigen)
    • Anti-HCV antibody
    • HIV antibody testing
    • ALT (alanine aminotransferase)
    • Renal function tests (creatinine, BUN)

The CDC guidelines specify baseline testing for anti-HCV and ALT in the context of occupational exposures 1. For nonoccupational exposures, updated 2025 CDC recommendations confirm baseline HBV serology (HBsAg, HBsAb, HBcAb), HCV antibody testing, and serum creatinine are required 2.

Complete Blood Count

  • Lavender-top (EDTA) tube for CBC
    • This is the standard anticoagulant tube for hematology testing
    • Research confirms lavender-top tubes are suitable and stable for hematological parameters 3

HCV RNA PCR

  • Lavender-top (EDTA) or Plasma Processing Tube (PPT)
    • Both are acceptable, though lavender-top tubes may yield slightly higher viral loads 4
    • The difference is not clinically significant for diagnostic purposes
    • PPTs contain plasma separator gel; standard lavender-top tubes do not

Critical Timing Considerations

The CDC guidelines emphasize that baseline testing should not delay initiation of post-exposure prophylaxis 1, 2, 5. Draw the blood samples immediately, but start PEP without waiting for results. HIV testing should preferably use rapid antibody or antigen-antibody combination tests to rule out pre-existing infection 2, 5.

Common Pitfalls to Avoid

  1. Do not delay PEP initiation waiting for lab results - The 72-hour window for PEP effectiveness is critical 5

  2. Ensure adequate sample volume - Collect sufficient blood in each tube type to avoid having to redraw the patient

  3. For HCV RNA testing specifically: While both lavender-top and PPT tubes are acceptable, be aware that your laboratory may have a preference. Research shows lavender-top tubes may detect HCV RNA more sensitively than PPTs 4, though both are clinically acceptable.

  4. Label tubes correctly - Color coding is not standardized internationally 6, so always verify tube type by reading the label, not just relying on cap color

Follow-up Testing Schedule

The same tube types will be needed for follow-up testing per CDC guidelines 1, 2:

  • HIV antibody testing at baseline, 4-6 weeks, 3 months, and 6 months post-exposure
  • HCV antibody and ALT at 4-6 months
  • HCV RNA at 4-6 weeks if earlier diagnosis is desired

References

6
Research

Colour coding for blood collection tube closures - a call for harmonisation.

Clinical chemistry and laboratory medicine, 2015

Related Questions

How should a patient with a positive anti‑HCV antibody test be evaluated and managed?
With a reactive anti‑HCV antibody screen, should I order a qualitative HCV RNA assay or a quantitative HCV RNA measurement?
In a 46-year-old male with a positive anti‑HCV antibody, HCV RNA of 2,283,553 IU/mL, normal liver function tests, normal abdominal ultrasound, and normal FibroScan, what is the appropriate management?
What is the next step for a patient with equivocal hepatitis C (HCV) antibody results for two months and undetectable hepatitis C virus (HCV) RNA by quantitative polymerase chain reaction (PCR)?
In a patient with a positive anti‑hepatitis C virus (anti‑HCV) antibody test but an undetectable hepatitis C virus (HCV) RNA polymerase chain reaction (PCR) viral load one month after initiating antiviral therapy, what does this indicate?
How can I safely transition a patient intolerant to labetalol (edema) and nifedipine (headaches) from nifedipine to metoprolol?
In a patient four weeks after myocardial infarction who develops new bilateral leg swelling, does this indicate that cardiac surgery is required?
What causes an intermittent itchy heat‑induced rash on the arms with recurrent purpuric lesions on the legs, and how should it be managed?
Are you able to read and interpret medical orders?
What is the appropriate oral sodium chloride replacement regimen for an adult with a serum sodium of 125 mEq/L who is not severely symptomatic?
How can I provide my medical notes for you to evaluate the seriousness of bilateral lower extremity edema four weeks after a myocardial infarction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.